Profile

Cover photo
Verified name
Sally Church
Works at Icarus Consultants
5,399 followers|68,548 views
AboutPostsPhotosYouTube

Stream

Sally Church

Shared publicly  - 
 
Several companies with oncolytic viruses had some interesting data at ASCO 2015... this is a hot new area we can expect a lot of deal activity in over the next 3-5 years.
William Coley first used live bacteria as an immune stimulant to treat cancer way back in 1893. Since then, however, progress with innate immunotherapy has been surprisingly very slow. Indeed, to d...
1
1
Quantum Paradigm's profile photo
Add a comment...

Sally Church

Shared publicly  - 
 
Will vaccines boost the immune response of checkpoint inhibitors in prostate cancer?  Maybe...
Interview with Dr James Gulley NCI on Prostate Cancer Immunotherapy at ASCO 2015
1
Add a comment...

Sally Church

Shared publicly  - 
 
This is a top tip...
Need to Improve Online productivity? Get more out of your time with this secret productivity weapon
1
1
Quantum Paradigm's profile photo
Add a comment...

Sally Church

Shared publicly  - 
 
Lots of new data emerging at #asco15 today...
Highlights from Plenary Sunday at 2015 ASCO annual meeting in Chicago
1
Add a comment...

Sally Church

Shared publicly  - 
 
A potentially transformative revolution is taking place in cancer research...
Dr Tom Gajewski is working on Aduro Biotech STING agonists that may have a major role to play in cancer immunotherapy
1
Add a comment...

Sally Church

Shared publicly  - 
 
Some interesting new data for combinations with AZD9291 in T790M lung cancer and new data for Ariad's brigatinib in ALK-positive tumours
2nd and 3rd generation ALK inhibitors look increasingly promising in crizotinib refractory patients as does targeting c-MET in combination with T790M inhibitors
1
Add a comment...
Have them in circles
5,399 people
Elliot Savett's profile photo
Rajesh Kumar Singh's profile photo
Tiziana Riva's profile photo
Marco Scott's profile photo
Tommy Vann's profile photo
Roberto Micozzi's profile photo
Fraser Hay's profile photo
Nauka Znanost's profile photo
Kim Blackmore's profile photo

Sally Church

Shared publicly  - 
 
When everyone zigs, zag... Roche are taking a very different world view of the cancer immunotherapy space
Interview with Dr William Pao on Roche Cancer Immunotherapy Strategy and why they don't need a CAR T cell therapy
1
Add a comment...

Sally Church

Shared publicly  - 
 
Nice post - worth checking out..,
This is the first in a weekly series of guest posts from mums who have changed career. We start with Sarah Arrow of Sarkemedia.com, creator of the very successful 30 Day Blogging Challenge. "Until ...
1
Add a comment...

Sally Church

Shared publicly  - 
 
Nice post from my friend +Yolanda Facio - check it out!
So it’s time to change things up a little bit around here… Many of you know that over the last few months I’ve been a little bit quiet. Cancer and chemotherapy will do that to you… you find you hav...
1
Add a comment...

Sally Church

Shared publicly  - 
 
No need to STRIVE to be better than bicalutamide any more... impressive data
AUA 2015 Results of the STRIVE clinical trial shows enzalutamide is superior to bicalutamide in MO M1 Prostate Cancer
1
Add a comment...

Sally Church

Shared publicly  - 
 
What's hot in breast cancer? Why, immunotherapy is!
The Checkpoints Show. Checkpoint inhibitors targeting PD1 PDL1 pathway show promise in triple negative breast cancer
1
1
Suzan St Maur's profile photo
Add a comment...

Sally Church

Shared publicly  - 
 
European Lung Cancer Conference 2015 AZD9291 EGFR Inhibitor showed longer PFS in NSCLC patients with a T790M mutation
1
Add a comment...
People
Have them in circles
5,399 people
Elliot Savett's profile photo
Rajesh Kumar Singh's profile photo
Tiziana Riva's profile photo
Marco Scott's profile photo
Tommy Vann's profile photo
Roberto Micozzi's profile photo
Fraser Hay's profile photo
Nauka Znanost's profile photo
Kim Blackmore's profile photo
Work
Occupation
Management Consultant
Employment
  • Icarus Consultants
    Management Consultant, present
  • Novartis
  • Sandoz UK
Story
Introduction
Who am I?
I'm a marketer, a scientist, a maverick, a consultant and a problem solver.

What do I do?
People come to me with their problems and we find creative solutions.  I'm a science and data geek we make data sing.

What sort of problems? 
Strategic marketing, competitive intelligence, landscape opportunity assessments, KOL market research, social media monitoring.  Find out more detail here

What sort of clients? 
Pharma and biotechnology companies. 
We specialise in oncology and hematology, but have also completed projects in immunology, diabetes, respiratory, CNS and many others.

How can you find or contact me?
Via my blog